Avidity Biosciences Stock Buy Hold or Sell Recommendation
| RNA Stock | USD 43.25 0.69 1.62% |
Considering the 90-day investment horizon and your slightly conservative level of risk, our recommendation regarding Avidity Biosciences is 'Strong Sell'. Macroaxis provides Avidity Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RNA positions.
Check out Avidity Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide. In addition, we conduct extensive research on individual companies such as Avidity and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Avidity |
Execute Avidity Biosciences Buy or Sell Advice
The Avidity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Avidity Biosciences. Macroaxis does not own or have any residual interests in Avidity Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Avidity Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Avidity Biosciences Trading Alerts and Improvement Suggestions
| Avidity Biosciences had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 9.56 M. Reported Net Loss for the year was (212.22 M) with loss before taxes, overhead, and interest of (141.18 M). | |
| Avidity Biosciences has about 398.22 M in cash with (119.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.64. | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635 |
Avidity Biosciences Returns Distribution Density
The distribution of Avidity Biosciences' historical returns is an attempt to chart the uncertainty of Avidity Biosciences' future price movements. The chart of the probability distribution of Avidity Biosciences daily returns describes the distribution of returns around its average expected value. We use Avidity Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Avidity Biosciences returns is essential to provide solid investment advice for Avidity Biosciences.
| Mean Return | 0 | Value At Risk | -7.08 | Potential Upside | 5.78 | Standard Deviation | 4.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Avidity Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Avidity Stock Institutional Investors
| Shares | State Street Corp | 2024-06-30 | 3.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.5 M | Geode Capital Management, Llc | 2024-06-30 | 2.3 M | Casdin Capital, Llc | 2024-09-30 | 2.1 M | Artisan Partners Limited Partnership | 2024-06-30 | 1.9 M | Boxer Capital Llc | 2024-09-30 | 1.7 M | Nuveen Asset Management, Llc | 2024-06-30 | 1.2 M | Polar Capital Holdings Plc | 2024-06-30 | 1.1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 990.2 K | Fmr Inc | 2024-09-30 | 16.8 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 10.9 M |
Avidity Biosciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 235K | 1.1M | 3.7M | 2.8M | 4.2M | 4.4M | |
| End Period Cash Flow | 94.6M | 321.7M | 320.7M | 340.6M | 185.4M | 200.2M | |
| Investments | (235K) | (6.7M) | (78.8M) | (190.0M) | (188.9M) | (179.4M) | |
| Change In Cash | 91.5M | 227.1M | (1.0M) | 19.9M | (155.3M) | (147.5M) | |
| Free Cash Flow | 2.3M | (38.2M) | (98.6M) | (139.1M) | (123.3M) | (117.1M) | |
| Depreciation | 348K | 373K | 639K | 1.4M | 2.1M | 2.2M | |
| Other Non Cash Items | 7.3M | 139K | 163K | (615K) | (8.3M) | (7.9M) | |
| Net Income | (24.7M) | (44.4M) | (118.0M) | (174.0M) | (212.2M) | (201.6M) | |
| Change To Netincome | 7.4M | 4.5M | 17.2M | 26.5M | 30.5M | 32.0M |
Avidity Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Avidity Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Avidity Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Avidity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 1.75 | |
σ | Overall volatility | 4.21 | |
Ir | Information ratio | -0.03 |
Avidity Biosciences Volatility Alert
Avidity Biosciences exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Avidity Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Avidity Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Avidity Biosciences Fundamentals Vs Peers
Comparing Avidity Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Avidity Biosciences' direct or indirect competition across all of the common fundamentals between Avidity Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Avidity Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Avidity Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Avidity Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Avidity Biosciences to competition |
| Fundamentals | Avidity Biosciences | Peer Average |
| Return On Equity | -0.28 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Operating Margin | (42.01) % | (5.51) % |
| Current Valuation | 3.5 B | 16.62 B |
| Shares Outstanding | 119.31 M | 571.82 M |
| Shares Owned By Insiders | 4.82 % | 10.09 % |
| Shares Owned By Institutions | 95.18 % | 39.21 % |
| Number Of Shares Shorted | 14.66 M | 4.71 M |
| Price To Earning | (12.91) X | 28.72 X |
| Price To Book | 3.38 X | 9.51 X |
| Price To Sales | 501.91 X | 11.42 X |
| Revenue | 9.56 M | 9.43 B |
| Gross Profit | (141.18 M) | 27.38 B |
| EBITDA | (233.5 M) | 3.9 B |
| Net Income | (212.22 M) | 570.98 M |
| Cash And Equivalents | 398.22 M | 2.7 B |
| Cash Per Share | 7.64 X | 5.01 X |
| Total Debt | 9.85 M | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 12.00 X | 2.16 X |
| Book Value Per Share | 12.64 X | 1.93 K |
| Cash Flow From Operations | (119.06 M) | 971.22 M |
| Short Ratio | 17.70 X | 4.00 X |
| Earnings Per Share | (2.88) X | 3.12 X |
| Target Price | 68.55 | |
| Number Of Employees | 253 | 18.84 K |
| Beta | 0.91 | -0.15 |
| Market Capitalization | 5.08 B | 19.03 B |
| Total Asset | 628.55 M | 29.47 B |
| Retained Earnings | (570.76 M) | 9.33 B |
| Working Capital | 530.63 M | 1.48 B |
| Current Asset | 50.65 M | 9.34 B |
| Current Liabilities | 16.97 M | 7.9 B |
Note: Disposition of 25000 shares by Teresa McCarthy of Avidity Biosciences at 14.22 subject to Rule 16b-3 [view details]
Avidity Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Avidity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 51428.68 | |||
| Daily Balance Of Power | 0.3026 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 42.89 | |||
| Day Typical Price | 43.01 | |||
| Price Action Indicator | 0.7 | |||
| Period Momentum Indicator | 0.69 |
About Avidity Biosciences Buy or Sell Advice
When is the right time to buy or sell Avidity Biosciences? Buying financial instruments such as Avidity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Avidity Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Providers Thematic Idea Now
Insurance Providers
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Avidity Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.88) | Revenue Per Share 0.103 | Quarterly Revenue Growth (0.17) | Return On Assets (0.18) | Return On Equity (0.28) |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.